Related Experiment Video
Updated: Aug 15, 2026
Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
BRCA1 RING domain cancer-predisposing mutations. Structural consequences and effects on protein-protein interactions
P S Brzovic1, J E Meza, M C King
1Department of Biochemistry and Biomolecular Structure Center, University of Washington, Seattle Washington 98195-7742, USA.
Abstract:
Cancer-predisposing missense mutations in the RING domain of BRCA1 primarily target Zn(2+)-liganding residues. Here we report on the structural consequences of such mutations introduced into the second Zn(2+) site (Site II) of the BRCA1 RING domain and their effect on the interaction with the BARD1 RING domain. Each of the BRCA1 Site II mutants still interact and form a stable heterodimer with BARD1. Limited proteolysis of BRCA1/BARD1 complexes, monitored by matrix-assisted laser desorption ionization time-of-flight spectrometry, show that the mutations cause a local structural perturbation that is primarily confined to the second Zn(2+) binding loop of the BRCA1 subunit. These findings are consistent with the structure of the BRCA1/BARD1 heterodimer, which shows this region is well removed from the helices required for dimerization with BARD1. Instead, the mutations alter a region of BRCA1 that appears to be required for interaction with ubiquitin-conjugating enzymes.
Insights
Cancer-predisposing mutations in the BRCA1 RING domain affect its interaction with BARD1. These mutations cause local structural changes in BRCA1, impacting its binding to ubiquitin-conjugating enzymes.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- BRCA1 is a tumor suppressor gene.
- Missense mutations in the BRCA1 RING domain are linked to cancer predisposition.
- These mutations often target residues essential for zinc ion (Zn(2+)) binding.
Purpose of the Study:
- To investigate the structural impact of cancer-predisposing mutations in the BRCA1 RING domain's second Zn(2+) binding site (Site II).
- To determine how these mutations affect the heterodimerization of BRCA1 with BARD1.
- To elucidate the functional consequences of these mutations on protein interactions.
Main Methods:
- Site-directed mutagenesis to introduce mutations into the BRCA1 RING domain (Site II).
- Formation of BRCA1/BARD1 heterodimers.
- Limited proteolysis coupled with matrix-assisted laser desorption ionization time-of-flight spectrometry (MALDI-TOF) to assess structural changes.
Main Results:
- BRCA1 Site II mutants successfully form stable heterodimers with BARD1.
- Limited proteolysis reveals local structural perturbations in the BRCA1 subunit, specifically within the second Zn(2+) binding loop.
- These structural changes are spatially distinct from the dimerization interface with BARD1.
Conclusions:
- Cancer-predisposing mutations in BRCA1 Site II do not disrupt BARD1 heterodimerization.
- The mutations induce localized structural alterations in BRCA1.
- These alterations suggest a role in modulating interactions with ubiquitin-conjugating enzymes, potentially affecting BRCA1's function in DNA repair or ubiquitination pathways.
More Related Videos
Related Concept Videos
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:38The Ras Gene
Ras is a superfamily...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:30Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
01:24Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...